United States · 
Who invested in Trace Biosciences?
Trace Biosciences's investors include National Science Foundation and National Institutes of Health.
20252026
$150KGrant$150KSeries A
United States · Series A startup
Who invested in Trace Biosciences
Funding summaryUpdated 26 Oct 2026
$300Kraised across 2 rounds since 2024, from 2 sources
$150KGrant$150KSeries A
- Latest round
- Series A, $150KJul 2026
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $150K Dec 2024
- Biggest round
- $150K Series A · Jul 2026
- Between rounds
- 19 months from the last two
The rounds
- Jul 2026Series A$150K2 returning
Source recordedSEC filing: $8.3M sold
- Dec 2024
Founders and team
From Trace Biosciences's own website: 3 on the team.
- Scott HoustonHead of Clinical Operations
- Hanna AdlerMarketing & Research Associate
- Harsh SantResearch Associate
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Trace Biosciences
How much has Trace Biosciences raised?
Trace Biosciences has raised $300K across 2 rounds since 2024.
When did Trace Biosciences last raise?
Trace Biosciences's most recent round was a Series A of $150K in Jul 2026.
What was Trace Biosciences's biggest round?
Its most recent round, $150K in Jul 2026, is also its largest on record.
Who backed Trace Biosciences first?
Trace Biosciences's first round on record, in Dec 2024, was backed by National Science Foundation and National Institutes of Health.
What stage is Trace Biosciences at?
Trace Biosciences's latest named round is a Series A, in Jul 2026.
Where is Trace Biosciences based?
Trace Biosciences is based in the United States.
Companies like Trace Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.